Magellan offloads microbiology business to Thermo Fisher to focus on clinical Dx
This article was originally published in Clinica
Executive Summary
Diagnostics firm Magellan Biosciences has sold its microbiology unit, TREK Diagnostic Systems, to Thermo Fisher Scientific in order to focus on its core clinical diagnostics businesses. Financial terms of the deal were not disclosed.